Artificial - and accelerated - intelligence: endless applications to expand health equity 

In the complex world of pediatric diseases, researchers need access to data to develop clinical trials and the participation of vulnerable patients to develop new devices and therapies. Both are in short supply, given that most children are born healthy, and most severe pediatric diseases are rare.
That creates a dilemma: how do researchers build a foundation to advance new treatments? Enter artificial intelligence (AI).